You have no items in your shopping cart.
RecombinantIP-10/CXCL10,Human [orb1494811]> 95% by SDS-PAGE and HPLC analyses.
8.6 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
50 μg, 10 μg, 1 mg- RecombinantTNF-α,Rat [orb1494606]
> 95% by SDS-PAGE and HPLC analyses.
17.4kDa, observed by reducing SDS-PAGE.
P. pastoris
10 μg, 50 μg, 1 mg - RecombinantTNF-α,Mouse(P.pastoris-expressed) [orb1494607]
> 95% as analyzed by reducing SDS-PAGE.
17kDa, observed by reducing SDS-PAGE.
P. pastoris
20 μg, 100 μg, 1 mg - RecombinantTNF-α,Human(P.pastoris-expressed) [orb1494608]
> 95% by SDS-PAGE analysis.
17.4kDa, observed by reducing SDS-PAGE.
P. pastoris
10 μg, 50 μg, 1 mg - RecombinantIP-10/CRG-2/CXCL10,Rat [orb1494635]
> 98% as analyzed by SDS-PAGE.
8.7 kDa, observed by reducing SDS-PAGE.
HEK 293
25 μg, 5 μg, 1 mg - RecombinantTNFRI,Human [orb1494664]
> 95% as analyzed by SDS-PAGE.
28~35 kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg >95% by SDS-PAGE and HPLC analyses.
Approximately 17.5 kDa. a single, non-glycosylated, polypeptide chain containing 157 amino acids fragment (77-233) and having a molecular mass of 21.85 kDa with an amino-terminal hexahistidine tag.
Escherichia coli.
1 mg, 50 μg, 10 μg>95% by SDS-PAGE and HPLC analyses.
Approximately 17.5 kDa. The recombinant protein preparation is a mixture of a 158 amino acid residue form containing an N-terminal methionine and a 157 amino acid residue form with the sequence of mature human TNF-α.
Escherichia coli.
1 mg, 50 μg, 10 μg- RecombinantIL-13,His,Mouse(CHO-expressed) [orb1494717]
> 95% as analyzed by SDS-PAGE.
14-30 kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg